References
- Nieschlag E, Swerdloff R, Behre HM, Gooren L J, Kaufman J M, Legros J J, Lunenfeld B, Morley J E, Schulman C, Wang C, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Eur Urol 2005; 48: 1–5
- Buvat J, Shabsigh R, Guay A, . Hormones, metabolism, aging, and men's health. Standard practice in sexual medicine, H Porst, J Buvat, the Standard Committee of the ISSM, et al. Blackwell Publishing, Oxford 2006; 225–286
- Hatzimouratidis H, Hatzichristou D. Testosterone and erectile function: an unresolved enigma. Eur Urol 2007; 52: 26–28
- Lunenfeld B, Niesschlag E. Testosterone therapy in the aging male. Aging Male 2007; 10: 139–153
- Vermeulen A. Androgen replacement therapy in the aging male - a critical evaluation. J Clin Endocrinol Metab 2001; 86: 2380–2390
- Yassin A A, Saad F. Treatment of sexual dysfunction of hypogonadal patients with long acting testosterone undecanoate (Nebido). World J Urol 2006; 24: 639–644
- Traish A M, Goldstein I, Kim N N. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 2007; 52: 54–70
- Isidori A M, Gianetta E, Gianfrilli D, et al. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol (Oxf) 2005; 63: 381–394
- Greenstein A, Mabjeesh N J, Sofer M, et al. Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed. J Urol 2005; 173: 530–532
- Shabsigh R. Hypogonadism and erectile dysfunction: the role for testosterone therapy. Int J Impot Res 2003; 15(suppl.4)S9–S13
- Meikle A W, Arver S, Dobs A S, et al. Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system. Urology 1997; 49: 191–196
- Kenny A M, Prestwood K M, Gruman C A, Marcello K M, Raisz L G. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 2001; 56: M266–272
- Ebert T, Jockenhövel F, Morales A, Shabsigh R. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel. Eur Urol 2005; 47: 137–146
- Roden E L, Morgentaler A. Risk of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 2004; 350: 482–492
- Gerstenbluth R E, Maniam P N, Corty E W, Seftel A D. Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement. J Androl 2002; 23: 922–926
- Wald M, Meacham R B, Ross L S, Niederberger C S. Testosterone replacement therapy for older men. J Androl 2006; 27: 126–132
- Wang C, Cunningham G, Dobs A, et al. Long-term testosterone gel (AndrGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. JCEM 2004; 89: 2085–2098
- Marks L S, Mazer N A, Mostaghel E, et al. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA 2006; 296: 2351–2361
- Hwang T I, Chen H E, Tsai T F, Lin Y C. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone. Int J Impot Res 2006; 18: 400–404
- Celayir S. Effects of different sex hormones on male rabbit urodynamics: an experimental study. Horm Res 2003; 60: 215–220
- McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 2006; 97(suppl. 2)23–28
- Isidori A M, Gianetta E, Greco E, et al. Effects of testosterone on body composition, body metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol 2005; 63: 280–293
- Jockenhovel F, Vogel E, Reinhardt W, Reinwein D. Effects of various modes of androgen substitution therapy on erythropoiesis. Eur J Med Res 1997; 2: 293–298